Microba Life Sciences Limited (ASX:MAP)
Australia flag Australia · Delayed Price · Currency is AUD
0.0870
+0.0010 (1.16%)
At close: Feb 4, 2026

Microba Life Sciences Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
15.6712.095.424.693.73
Revenue Growth (YoY)
29.60%123.06%15.60%25.62%28.31%
Cost of Revenue
8.236.182.742.321.69
Gross Profit
7.445.912.682.372.04
Selling, General & Admin
22.5216.0110.1810.277.31
Research & Development
2.0110.849.345.382.1
Other Operating Expenses
3.092.031.751.440.93
Operating Expenses
32.0531.7422.9118.6411.56
Operating Income
-24.61-25.84-20.23-16.27-9.52
Interest Expense
-0.18-0.07-0.06-0.06-0.02
Interest & Investment Income
0.5810.880.050.1
Currency Exchange Gain (Loss)
1.760.10.370.49-0.05
Other Non Operating Income (Expenses)
2.935.826.374.321.97
EBT Excluding Unusual Items
-19.52-18.98-12.67-11.46-7.52
Merger & Restructuring Charges
--1.01---
Other Unusual Items
4.47----
Pretax Income
-15.05-19.99-12.67-11.46-7.52
Income Tax Expense
-0.11-0.050.010.01-
Net Income
-14.94-19.94-12.68-11.47-7.52
Net Income to Common
-14.94-19.94-12.68-11.47-7.52
Shares Outstanding (Basic)
448410314223183
Shares Outstanding (Diluted)
448410314223183
Shares Change (YoY)
9.40%30.42%40.87%21.61%17.01%
EPS (Basic)
-0.03-0.05-0.04-0.05-0.04
EPS (Diluted)
-0.03-0.05-0.04-0.05-0.04
Free Cash Flow
-12.34-17.05-12.94-12.08-7.43
Free Cash Flow Per Share
-0.03-0.04-0.04-0.05-0.04
Gross Margin
47.49%48.84%49.41%50.46%54.61%
Operating Margin
-157.05%-213.71%-373.24%-347.05%-255.09%
Profit Margin
-95.34%-164.92%-233.95%-244.64%-201.58%
Free Cash Flow Margin
-78.75%-141.06%-238.82%-257.75%-199.04%
EBITDA
-22.47-23.67-19.09-15.56-8.95
EBITDA Margin
-143.43%-195.80%---239.87%
D&A For EBITDA
2.132.161.140.720.57
EBIT
-24.61-25.84-20.23-16.27-9.52
EBIT Margin
-157.05%-213.71%---255.09%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.